176 related articles for article (PubMed ID: 30585820)
21. Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study.
Vezzosi D; Cardot-Bauters C; Bouscaren N; Lebras M; Bertholon-Grégoire M; Niccoli P; Levy-Bohbot N; Groussin L; Bouchard P; Tabarin A; Chanson P; Lecomte P; Guilhem I; Carrere N; Mirallié E; Pattou F; Peix JL; Goere D; Borson-Chazot F; Caron P; Bongard V; Carnaille B; Goudet P; Baudin E
Eur J Endocrinol; 2015 Mar; 172(3):309-19. PubMed ID: 25538206
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry.
Lévy-Bohbot N; Merle C; Goudet P; Delemer B; Calender A; Jolly D; Thiéfin G; Cadiot G;
Gastroenterol Clin Biol; 2004 Nov; 28(11):1075-81. PubMed ID: 15657529
[TBL] [Abstract][Full Text] [Related]
23. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
24. Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1: An Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines study.
Santucci N; Ksiazek E; Pattou F; Baud G; Mirallié E; Frey S; Trésallet C; Sébag F; Guérin C; Mathonnet M; Christou N; Donatini G; Brunaud L; Gaujoux S; Ménégaux F; Najah H; Binquet C; Goudet P; Lifante JC
Ann Surg; 2024 Feb; 279(2):340-345. PubMed ID: 37389888
[TBL] [Abstract][Full Text] [Related]
25. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
Gatta-Cherifi B; Chabre O; Murat A; Niccoli P; Cardot-Bauters C; Rohmer V; Young J; Delemer B; Du Boullay H; Verger MF; Kuhn JM; Sadoul JL; Ruszniewski P; Beckers A; Monsaingeon M; Baudin E; Goudet P; Tabarin A
Eur J Endocrinol; 2012 Feb; 166(2):269-79. PubMed ID: 22084155
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
27. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
van Beek DJ; Nell S; Pieterman CRC; de Herder WW; van de Ven AC; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Surg Oncol; 2019 Nov; 120(6):966-975. PubMed ID: 31401809
[TBL] [Abstract][Full Text] [Related]
29. High Tumor Uptake on
De Rycke O; Perrier M; Ouvrard É; Mennetrey C; Lachachi C; Bando-Delaunay A; Morland D; Goichot B; Taieb D; Walter T; Cadiot G; Cros J; Hentic O; Ruszniewski P; Lebtahi R; Imperiale A; de Mestier L
J Nucl Med; 2023 Nov; 64(11):1699-1705. PubMed ID: 37652547
[TBL] [Abstract][Full Text] [Related]
30. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
[TBL] [Abstract][Full Text] [Related]
33. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
Lairmore TC; Chen VY; DeBenedetti MK; Gillanders WE; Norton JA; Doherty GM
Ann Surg; 2000 Jun; 231(6):909-18. PubMed ID: 10816635
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms.
Liu JB; Cai J; Dhir M; Paniccia A; Zureikat AH; Ramonell KM; McCoy KL; Carty SE; Yip L
Ann Surg Oncol; 2022 Nov; 29(12):7808-7817. PubMed ID: 35963905
[TBL] [Abstract][Full Text] [Related]
35. Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content.
Heymann MF; Hamy A; Triau S; Miraillé E; Toquet C; Chomarat H; Cohen C; Maitre F; Le Bodie MF
Hepatogastroenterology; 2004; 51(59):1367-71. PubMed ID: 15362754
[TBL] [Abstract][Full Text] [Related]
36. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
37. Surgery to cure the Zollinger-Ellison syndrome.
Norton JA; Fraker DL; Alexander HR; Venzon DJ; Doppman JL; Serrano J; Goebel SU; Peghini PL; Roy PK; Gibril F; Jensen RT
N Engl J Med; 1999 Aug; 341(9):635-44. PubMed ID: 10460814
[TBL] [Abstract][Full Text] [Related]
38. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Kouvaraki MA; Shapiro SE; Cote GJ; Lee JE; Yao JC; Waguespack SG; Gagel RF; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):643-53. PubMed ID: 16680581
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours.
Donegan D; Singh Ospina N; Rodriguez-Gutierrez R; Al-Hilli Z; Thompson GB; Clarke BL; Young WF
Clin Endocrinol (Oxf); 2017 Feb; 86(2):199-206. PubMed ID: 27770475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
